Sydney—It’s 07:37 AEST on May 6, 2026.
Pamela Maunsell Wall, widow of Codan co-founder Ian Wall, unloaded 8 million Codan Limited shares for A$312 million, slashing her stake in the Australian technology firm from 19.14% down to 14.74%, according to an ASX filing. The shares moved at A$39.00 apiece in a block trade—typically channeled to professional investors.
Timing here is everything. Less than a week after Codan lifted its fiscal 2026 earnings guidance, the trade hit, coming just a day after shares reached A$44.52, their latest high in market data. Investors are left to decide: was this a straightforward bout of profit-taking, or does it suggest the rally might have overshot?
Codan shares slid 9.38% to A$39.80 Tuesday, down from a A$43.92 finish on Monday, according to Investing.com data. The block traded at roughly an 11% discount to that previous close—a level that typically helps move big institutional positions fast.
Canaccord Genuity (Australia) led the sale, according to a filing published Tuesday at 2:30 p.m. AEST. Settlement comes Thursday, May 7.
CCK Lawyers, representing Dr Wall, stated the bulk of the net proceeds are earmarked for a donation to the Ian and Pamela Wall Foundation—established to back the philanthropic initiatives of Dr Wall and her late husband. According to the letter, Dr Wall isn’t planning to offload additional Codan shares right now and doesn’t anticipate selling more stock in the upcoming 12 months.
The sale leaves Codan’s guidance untouched, but Dr Wall continues to hold a hefty chunk. Disclosure shows he still owns 26,808,151 shares—worth roughly A$1.07 billion at Tuesday’s A$39.80 close.
On April 29, Codan projected its fiscal 2026 EBIT to reach roughly A$235 million, with NPAT coming in around A$170 million. Those numbers, according to the company, would mark increases of more than 60% over its expected results for fiscal 2025.
Both sides of the business contributed to the upgrade. Codan now sees its Communications unit hitting the upper edge of its 15% to 20% revenue-growth target for fiscal 2026, with the 30% segment profit margin arriving a year sooner than they’d mapped out. Over at Minelab, revenue is running ahead of a robust first half, with a tailwind from the gold price and recent product launches.
Codan’s lineup isn’t cut from quite the same cloth as other local defence-tech names. Over at DroneShield and Electro Optic Systems, you’re looking at portfolios that lean hard into counter-drone systems and defence electronics. Codan, though, pairs up its defence and public-safety comms with Minelab’s metal detectors—a mix that means broader revenue streams, but it also muddies the direct impact from defence sector news.
Still, after a sharp re-rating, the risks are showing. Any cooling in defence demand, a dip in unmanned-systems orders, or softer gold-linked detector sales could put pressure on those higher targets. Codan, for its part, flagged that its forward-looking statements come with risks and uncertainties—actual results might not match up.
Despite Tuesday’s drop, Codan is still sitting 144.62% higher than a year ago. Shares have swung between A$15.89 and A$44.52 in that 52-week window, according to market data. With gains like that, execution matters more—A$39 is now the block price to watch.
Codan set Aug. 20 for its next test: that’s when full-year fiscal 2026 results drop. Until then, investors are left sizing up a straightforward dilemma—do institutions keep stepping in close to the block price, or does the founder-family sell-down signal a shift to a more reserved stance on Codan Limited shares?
